FDA Approves Lilly's Zyprexa For Two Adolescent Indications
The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with b...
PharmaceuticalOnline,
Tue Dec 08 02:22:34 PST 2009
• Found on Yahoo! News
Eli Lilly predicts earnings growth, touts pipeline
FILE - In this April 10, 2003 file photo, bottles filled with the drug Zyprexa sits on the packaging line at the Eli Lilly & Co. Dry Products Packaging Facility in Indianapolis. Eli Lilly s...
MalaysiaNews.net,
Thu Dec 10 11:21:09 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
9:30am -- AG Gets $10.9 Million for N.M. From Drug Settlement
Eli Lilly and Company pleaded guilty to January to illegally marketing Zyprexa. Attorney General Gary King today announced completion of a $10.9 million settlement for New Mexico with drug ...
Albuquerque Journal,
Thu Dec 10 08:47:33 PST 2009
• Found on Yahoo! News
US FDA approves Lilly's Zyprexa to treat schizophrenia & bipolar I disorder in tee...
The US Food and Drug Administration (FDA) approved Zyprexa (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I ...
PharmaBiz,
Sun Dec 06 21:51:33 PST 2009
• Found on Yahoo! News
Eli Lilly predicts earnings growth, touts pipeline
Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dropped as its 2009 forecast fell short of Wall Street expectations.
AP via Yahoo! News,
Thu Dec 10 13:39:39 PST 2009
• Found on Yahoo! News
Health Highlights: Dec. 10 2009
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
HealthDay via Yahoo! News,
Thu Dec 10 09:04:39 PST 2009
• Found on Yahoo! News
Eli Lilly sees growth in earnings next year
Eli Lilly said Thursday it still expects its earnings per share to grow in the double-digit range through 2011 and added it plans to launch two new medicines per year starting in 2013.
AP via Yahoo! News,
Thu Dec 10 08:00:59 PST 2009
• Found on Yahoo! News
Lilly suggests profit stumble after patent cliff
Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations, but suggested earnings could fall after its biggest drugs lose patent protection between 2011 and 2014.
Reuters via Yahoo! News,
Thu Dec 10 07:21:49 PST 2009
• Found on Yahoo! News
Lilly forecasts sidestep 2011-2014 patent cliff
Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations but gave no hint of how profit might pan out after its biggest drugs lose patent protection between 2011 and 20...
Reuters via Yahoo! News,
Thu Dec 10 05:29:28 PST 2009
• Found on Yahoo! News
Traders Brace for Drop in Eli Lilly Shares
Options traders are betting that Eli Lilly shares will continue to fall after the drugmaker failed to address patent questions.
TheStreet.com,
Thu Dec 10 15:56:24 PST 2009
• Found on Yahoo! News
Coca-Cola, El Paso, Goodrich Petroleum: U.S. Equity Movers
Dec. 10 (Bloomberg) -- Shares of the following companies are having unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 1:40 p.m. in New York.
Bloomberg,
Thu Dec 10 14:01:39 PST 2009
• Found on Yahoo! News
Lilly Falls as Analysts Fault Drug Research Schedule (Update3)
Dec. 10 (Bloomberg) -- Eli Lilly & Co. said it plans to introduce two medicines a year starting in 2013 in an effort to replace revenue lost after its top-seller loses patent protection. Th...
Bloomberg,
Thu Dec 10 13:51:47 PST 2009
• Found on Yahoo! News
Lilly's earnings outlook sparks stock sell-off
Can Eli Lilly and Co. keep its sales and profits from plunging off the edge of a cliff in two years? Wall Street apparently doesn't think so.
The Indianapolis Star,
Thu Dec 10 22:40:24 PST 2009
• Found on Yahoo! News
Health Highlights: Dec. 10 2009
About 100,000 packages of Alka-Seltzer cold capsules have been recalled because of a labeling error, says Bayer Healthcare.
Forbes,
Thu Dec 10 09:34:08 PST 2009
• Found on Yahoo! News
A Tale of Two Lillys
Charles Dickens could have written this story.
The Motley Fool,
Thu Dec 10 13:42:24 PST 2009
• Found on Yahoo! News
Health Highlights: Dec. 9, 2009
Title: Health Highlights: Dec. 9, 2009 Category: Health News Created: 12/9/2009 12:10:00 PM Last Editorial Review: 12/10/2009
MedicineNet.com,
Thu Dec 10 13:28:40 PST 2009
• Found on Yahoo! News
Akeena, FuelCell, Gannett, Hansen Medical: U.S. Equity Movers
Dec. 10 (Bloomberg) -- Shares of the following companies are having unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 10:55 a.m. in New York.
Bloomberg,
Thu Dec 10 08:46:27 PST 2009
• Found on Yahoo! News
Biotech Stocks: Drug stocks climb; Lilly falls on forecast
Drug stocks climb in early action while shares of Eli Lilly & Co. fall after it issues a mixed financial forecast.
Market Watch,
Thu Dec 10 08:10:28 PST 2009
• Found on Yahoo! News
Entropic, Pennichuck, United Technologies: U.S. Equity Movers
Dec. 10 (Bloomberg) -- Shares of the following companies are having unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 10 a.m. in New York.
Bloomberg,
Thu Dec 10 07:46:41 PST 2009
• Found on Yahoo! News